CMPS
COMPASS PathwaysยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CMPS Profile
Compass Pathways Plc
A UK developer of psilocybin therapy for the treatment of resistant depression
Pharmaceutical
--
09/18/2020
NASDAQ Stock Exchange
166
12-31
Depository Receipts (Ordinary Shares)
33 Broadwick Street, London W1F 0DQ, United Kingdom
--
COMPASS Pathways plc is incorporated in England and Wales. COMPASS Pathways plc is a mental health care company that promotes patient access to evidence-based mental health care innovations. The company is motivated by the need to find better ways to help and empower people with mental health challenges who are not helped by existing therapies, and is pioneering a new psilocybin treatment model that combines psilocybin with psychological support.
